Trial Profile
A study investigating the effect of pomalidomide in real world United Kingdom patients with relapsed or refractory myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2015
Price :
$35
*
At a glance
- Drugs Pomalidomide (Primary) ; Dexamethasone
- Indications Myeloma
- Focus Therapeutic Use
- 05 Aug 2015 New trial record
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.